NCT00079638View on ClinicalTrials.gov

Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

April 30, 2004

Study Completion Date

May 31, 2005

Conditions
DyslipidemiaCoronary Heart DiseaseAtherosclerosisStrokeDiabetes
Interventions
DRUG

Niacin

DRUG

Atorvastatin

DRUG

Simvastatin

DRUG

Ezetimibe

DRUG

Rosuvastatin

Sponsors
All Listed Sponsors
lead

Kos Pharmaceuticals

INDUSTRY

NCT00079638 - Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL | Biotech Hunter | Biotech Hunter